Follow us on:
Dedication / Services
To provide 50000 services and products to global scientific research units every year

Lorvotuzumab mertansine

DESCRIPTION CATALOG # SIZE PRICE
Anti-Human CD56 Therapeutic Antibody TAB-188 1mg Please Inquiry
Product Detail
Cat
TAB-188
Product Overview
Recombinant monoclonal antibody to CD56. Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate of lorvotuzumab linked to mertansine intended for CD56 positive cancers (e.g. small-cell lung cancer, ovarian cancer).
Target
CD56
Type
IgG1 - kappa
Immunogen
The details of the immunogen for this antibody are not available.
Species Reactivity
Human
Expression Host
CHO
Applications
Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, ICC and most other immunological methods.
CAS
1008106-64-6
Specificity
Tested positive against native human antigen.
Predicted N terminal
H chain: QVQLVES; L chain: DVVMTQS
Molecular Weight
146433
Purity
>95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
Size
1mg
Storage
Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.
Background
Antigen Description
This protein is a cell adhesion molecule involved in neuron-neuron adhesion, neurite fasciculation, outgrowth of neurites, etc.
Gene ID
4684
Synonyms
NCAM1; neural cell adhesion molecule 1; CD56; NCAM; neural cell adhesion molecule, NCAM; antigen recognized by monoclonal 5.1H11; MSK39;
Download Datasheet:

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Online Inquiry
Please input "biolabs"(case insensitive) as verification code.
Loading...
Contact Us

USA
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email: 

Europe
Tel: 44-207-097-1828


© 2007 - 2017 Creative-Biolabs All Rights Reserved